federal_register: 2016-07899

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2016-07899 Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of Notice Notice The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. This meeting was announced in the Federal Register of March 16, 2016. The amendment is being made to reflect a change in the Date and Time portion of the document. The Date of the meeting is changed to May 25, 2016. There are no other changes. 2016-04-06 2016 4 https://www.federalregister.gov/documents/2016/04/06/2016-07899/endocrinologic-and-metabolic-drugs-advisory-committee-amendment-of-notice https://www.govinfo.gov/content/pkg/FR-2016-04-06/pdf/2016-07899.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. This meeting was announced in the Federal Register of March 16, 2016. The amendment is being made...  

Links from other tables